What is Damora Therapeutics, Inc. Common Stock's Market Cap?

Damora Therapeutics, Inc. Common Stock's Market Cap is $1.8B, based on as-reported figures from SEC (XBRL) filings.

What is Damora Therapeutics, Inc. Common Stock's Enterprise Value?

Damora Therapeutics, Inc. Common Stock's Enterprise Value is $1.3B, based on as-reported figures from SEC (XBRL) filings.

What is Damora Therapeutics, Inc. Common Stock's EV / EBITDA?

Damora Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Damora Therapeutics, Inc. Common Stock's Net Income (TTM)?

Damora Therapeutics, Inc. Common Stock's Net Income (TTM) is -$262.8M, based on as-reported figures from SEC (XBRL) filings.

What is Damora Therapeutics, Inc. Common Stock's EBITDA?

Damora Therapeutics, Inc. Common Stock's EBITDA is -$270.6M, based on as-reported figures from SEC (XBRL) filings.

What is Damora Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Damora Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -4.26, based on as-reported figures from SEC (XBRL) filings.

What is Damora Therapeutics, Inc. Common Stock's Net Debt?

Damora Therapeutics, Inc. Common Stock's Net Debt is -$540.5M, based on as-reported figures from SEC (XBRL) filings.

Damora Therapeutics, Inc. Common Stock (DMRA) Financial Statements

Damora Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00XMLGWD4

XNAS · usd

29.17▼ 0.89 (-2.96%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close30.06

Day's Range28.89 – 30.74

52-Week Range16.50 – 34.89

Volume559.5K

Avg Volume339.3K

Share Statistics

Shares Outstanding

Employees7

ExchangeXNAS

Listed2020-10-29

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Damora Therapeutics, Inc. Common Stock (DMRA)

What is Damora Therapeutics, Inc. Common Stock's Market Cap?: Damora Therapeutics, Inc. Common Stock's Market Cap is $1.8B, based on as-reported figures from SEC (XBRL) filings.
What is Damora Therapeutics, Inc. Common Stock's Enterprise Value?: Damora Therapeutics, Inc. Common Stock's Enterprise Value is $1.3B, based on as-reported figures from SEC (XBRL) filings.
What is Damora Therapeutics, Inc. Common Stock's EV / EBITDA?: Damora Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Damora Therapeutics, Inc. Common Stock's Net Income (TTM)?: Damora Therapeutics, Inc. Common Stock's Net Income (TTM) is -$262.8M, based on as-reported figures from SEC (XBRL) filings.
What is Damora Therapeutics, Inc. Common Stock's EBITDA?: Damora Therapeutics, Inc. Common Stock's EBITDA is -$270.6M, based on as-reported figures from SEC (XBRL) filings.
What is Damora Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Damora Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -4.26, based on as-reported figures from SEC (XBRL) filings.
What is Damora Therapeutics, Inc. Common Stock's Net Debt?: Damora Therapeutics, Inc. Common Stock's Net Debt is -$540.5M, based on as-reported figures from SEC (XBRL) filings.